BridgeMD
New treatment option for Ataxic Cerebral Palsy
Official title Effects of VOJTA Technique on Ataxic Cerebral Palsy.
ClinicalTrials.gov ID: NCT07291128
What this study is testing
- What it's testing
- Ataxic cerebral palsy (CP) is the least common subtype of CP and it is primarily caused by cerebellar damage that results in hypotonia, impaired balance, poor coordination, tremors, wide-based gait, and significant difficulties in trunk stability and uncontrolled movements. These impairments greatly affect functional mobility and independence in life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 6
You may be able to join if
- Both male and female participants would be included
- Children diagnosed with ataxic cerebral palsy.
- Age range of participants will be 2 to 6 years old.
- Participants included will be at level 2 on gross motor function classification scale.
- Participants included will have ATNR reflex.
You likely can't join if
- Presence of severe comorbidities i.e. neurological or orthopedic conditions.
- Patients having significant cognitive deficits
- Down syndrome, hydrocephalus, epilepsy, autism and medically ill children
- Children with visual or auditory deficits affecting postural control and balance assessment.
- Ongoing pharmacological treatment (e.g., muscle relaxants or antiepileptic) likely to influence muscle tone or motor function during the study period
See the full eligibility criteria
- Both male and female participants would be included
- Children diagnosed with ataxic cerebral palsy.
- Age range of participants will be 2 to 6 years old.
- Participants included will be at level 2 on gross motor function classification scale.
- Participants included will have ATNR reflex.
- Stable medical condition for the past three months with no hospitalizations.
- Presence of severe comorbidities i.e. neurological or orthopedic conditions.
- Patients having significant cognitive deficits
- Down syndrome, hydrocephalus, epilepsy, autism and medically ill children
- Children with visual or auditory deficits affecting postural control and balance assessment.
- Ongoing pharmacological treatment (e.g., muscle relaxants or antiepileptic) likely to influence muscle tone or motor function during the study period
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 6 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.